Analysis for BX
- 📈 Growth — 26/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 18/20
- 💵 Valuation — 15/20
- ⚠️ Risk — 8/10
Summary:
📈 Growth & Financial Trajectory
Eight quarters show a steady revenue enhancement from about $2.80B in 2024 Q1 to $5.04B in 2026 Q2, a growth of roughly 80%, with occasional dips (notably 2025 Q3 after 2025 Q4). Net income rose from about $1.63B to $2.36B, signaling stronger profitability despite volatility.
💰 Margins & Cash Flow
Operating margin sits in the 40-50% range, with 2026 Q2 peaking above that. Net income margin tracks this strength. Cash flow from operating activities remained robust, e.g., $1.94B in 2026 Q2, while investing cash flow was cash outflow and financing cash flow negative, yielding a modest net cash improvement.
🛡️ Balance Sheet & Liquidity
Total assets near $50B; long-term debt around $13.3B; equity around $21.1B; current liabilities generally aligned with current assets, supporting liquidity. The balance sheet shows durable capital structure with temporary redeemable equity.
⚠️ Key Drivers & Risks
- Drivers: Strong fee-based earnings from alternative asset management; diversified asset classes and growth in performance fees.
- Risks: Market cyclicality and reliance on performance fees; valuation sensitivity and potential fee compression.